Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia

Karaboga B., ÇİLLİ A.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.63, no.2, pp.94-101, 2015 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 63 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.5578/tt.9110
  • Journal Name: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.94-101
  • Keywords: Community acquired pneumonia, ampicilline-sulbactam, fluoroquinolone
  • Akdeniz University Affiliated: Yes

Abstract

Introduction: For hospitalized patients, monotherapy with a respiratory Fluoroquinolone (F) and dual therapy combination a ampicilline-sulbactam + a macrolide (AS+ M) are extensively used in the treatment of community-acquiredpneumonia (CAP). In this study, empirical AS + M combination therapy versus F monotherapy was compared in hospitalized adult CAP patients.